comparemela.com
Home
Live Updates
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks : comparemela.com
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Some companies, however, reported a market capitalisation decline, including Gilead Sciences and Roche.
Related Keywords
Eli Lilly ,
Novo Nordisk ,
Johnson ,
Pharma Intelligence Center ,
Biden Harris Administration ,
Drug Administration ,
Merck Co ,
Gilead Sciences ,
Drugs Database ,
Pharma Intelligence ,
Harpoon Therapeutics ,
Cerevel Therapeutics ,
Inflation Reduction Act ,
Pharmaceutical Technology ,
comparemela.com © 2020. All Rights Reserved.